Annual Working Capital
$617.02 M
+$538.74 M+688.22%
December 31, 2024
Summary
- As of March 2, 2025, DYN annual working capital is $617.02 million, with the most recent change of +$538.74 million (+688.22%) on December 31, 2024.
- During the last 3 years, DYN annual working capital has risen by +$263.35 million (+74.46%).
- DYN annual working capital is now at all-time high.
Performance
DYN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
N/A
December 31, 2024
Summary
- DYN quarterly working capital is not available.
Performance
DYN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DYN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +688.2% | - |
| 3 y3 years | +74.5% | - |
| 5 y5 years | +4875.6% | - |
DYN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +688.2% | ||
| 5 y | 5-year | at high | +4875.6% | ||
| alltime | all time | at high | +8185.5% |
Dyne Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $617.02 M(+688.2%) | - |
| Sep 2024 | - | $693.13 M(-9.1%) |
| Jun 2024 | - | $762.57 M(+63.7%) |
| Mar 2024 | - | $465.78 M(+495.0%) |
| Dec 2023 | $78.28 M(-67.0%) | $78.28 M(-43.5%) |
| Sep 2023 | - | $138.52 M(-28.2%) |
| Jun 2023 | - | $192.95 M(-15.2%) |
| Mar 2023 | - | $227.63 M(-4.2%) |
| Dec 2022 | $237.51 M | $237.51 M(+1.1%) |
| Sep 2022 | - | $234.91 M(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $272.31 M(-15.2%) |
| Mar 2022 | - | $321.21 M(-9.2%) |
| Dec 2021 | $353.67 M(+4.6%) | $353.67 M(-11.9%) |
| Sep 2021 | - | $401.30 M(-10.2%) |
| Jun 2021 | - | $446.75 M(-5.7%) |
| Mar 2021 | - | $473.62 M(+40.1%) |
| Dec 2020 | $338.12 M(+2626.6%) | $338.12 M(-9.9%) |
| Sep 2020 | - | $375.16 M(+166.2%) |
| Jun 2020 | - | $140.95 M(+1036.6%) |
| Dec 2019 | $12.40 M(+66.5%) | $12.40 M |
| Dec 2018 | $7.45 M | - |
FAQ
- What is Dyne Therapeutics annual working capital?
- What is the all time high annual working capital for Dyne Therapeutics?
- What is Dyne Therapeutics annual working capital year-on-year change?
- What is the all time high quarterly working capital for Dyne Therapeutics?
What is Dyne Therapeutics annual working capital?
The current annual working capital of DYN is $617.02 M
What is the all time high annual working capital for Dyne Therapeutics?
Dyne Therapeutics all-time high annual working capital is $617.02 M
What is Dyne Therapeutics annual working capital year-on-year change?
Over the past year, DYN annual working capital has changed by +$538.74 M (+688.22%)
What is the all time high quarterly working capital for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly working capital is $762.57 M